 |
Can
Atopy Be Prevented? |
| |
The
Fetal and Infant Origins of Allergy
John
O. Warner, MD
|
| |
Diet
and Breast Feeding - Does Their Manipulation Make a Difference
Scott
T. Weiss, MD
|
| |
Pets,
Endotoxins, and Dust Mite - Avoid or Expose
Thomas
A. E. Platts - Mills, MD
|
| |
Panel
Discussion
Panel
|
 |
Eosinophils
as an Effector Cell in Asthma? |
| |
The
Role of Eosinophils in Mechanisms of Asthma
William
W. Busse, MD
|
| |
Eosinophils
and Asthma: Lessons From Animal Models
Harald
Renz, MD
|
| |
The
role of Eosinophil in Repair Processes
Patrick
Flood-Page, MD
|
| |
Panel
Discussion
Panel
|
 |
Neuroendocrine
Influence on Allergy and Asthma |
| |
Psychoneuroimmunology:
Physiological Basis for Behavior –
Associated Immune Changes
Gailen
D. Marshall, MD. PhD
|
| |
Stress
and Asthma: Mechanisms as a Basis for Future Interventions
Rosalind
Wright, MD
|
| |
Assessing
Stress in the Allergic / Asthmatic Patient: Limitations
and Potentials
Jack
H. Nassau, PhD
|
| |
Neuropeptides
and Allergic Inflammation: Impact on Allergy
and Asthma
Gailen
D. Marshall, MD. PhD
|
| |
Panel
Discussion
Panel
|
 |
Current
Issues in Drug Allergy |
| |
Office
Evaluation of Non-Penicillin Antibiotic Sensitivity
Stephen
A. Tilles, MD
|
| |
NSAID
Intolerance: Are Cox –2 Inhibitors Safe?
Ronald
A. Simon, MD
|
| |
Adverse
Reactions to Newer Biologic Agents
Richard
W. Weber, MD
|
| |
Panel
Discussion
Panel
|
 |
ABAI
Special Session Update on Certification and Maintenance of Certification
in Allergy/Immunology |
| |
The
Past and Present of Board Certification in Allergy / Immunology
John
W. Yunginger, MD
|
| |
Maintenance
of Certification: How Did We Get Here and
Where are We Going?
Thomas
Casale, MD
|
| |
Special
Lecture: The Future of Allergy/Immunology as a Specialty
Henry
G. Herrod, MD
|
 |
Advances
in Genomic Science and Its Applications to Asthma |
| |
Recent
Developments in the Genetics of Asthma
Larry
Borish, MD
|
| |
The
Relationship Between T-bet Deficiency and Asthma
Susetta
Finotto, PhD
|
| |
Pharmacogenetics
and the Treatment of Asthma
Elliot
Israel, MD
|
| |
Panel
Discussion
Panel
|
 |
What
Make Persistent Asthma Persistent? |
| |
Physiologic
Abnormalitiess in Asthma – Start Early
Scott
T. Weiss, MD
|
| |
Risk
Factors for Persistent Asthma
Bradley
E. Chipps, MD
|
| |
Regulation
of Innate Immune Responses and Inflammation in the
Airways by Glucocorticoids
Robert
P. Schleimer, PhD
|
| |
Pathophysiologic
Evidence of Remodeling: When Does It Start and
Can It Be Stopped?
Monica
Kraft, MD
|
 |
Past
Presidents' Breakfast |
| |
State
of the College
William
E. Berger, MD, MBA
|
 |
Bela
Schick Lecture |
| |
Emotional
Intelligence in Medicine: Does High IQ Mean
High Quality Care?
Susan
R. Wynn, MD
|
 |
Point/Counterpoint |
| |
Leukotriene
Antagonists are the Best Agents for the Initial Treatment
for Mild Asthma
Elliot
Israel, MD
|
| |
Intradermal
Allergy Skin Testing is Useful for the Diagnosis of
Allergic Sensitivities
Philip
Lieberman, MD and William K. Dolen, MD
|
 |
Immunotherapy
Collegium Track 1 |
| |
Efficacy
and Preventive Aspects of Immunotherapy
H.J.
Malling, MD
|
| |
Conventional
Immunotherapy vs. Adjuvant Immunotherapy with
Immunostimulatory DNA Vaccines: Mechanisms of Action and
Clinical Effects
Peter
S. Creticos, MD
|
| |
New
Developments and Old Ghosts – Oral Immunotherapy, Bacterial
(Endotoxin Vaccines)
Richard
W. Weber, MD
|
| |
Panel
Discussion
Panel
|
 |
Immunotherapy
Collegium Track 4 |
| |
Collegium
Keynote Address – Immunotherapy: Doing it Right!
Harold
S. Nelson, MD
|